Ping Zhang joined Gyre Therapeutics as Executive Chairman, while Dan Weng was appointed to the board. Their backgrounds include ICON plc, Mass General Hospital, and UC.
2 reports, 2 independent
Updated Aug 22
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ping Zhang joined Gyre Therapeutics as Executive Chairman, while Dan Weng was appointed to the board. Their backgrounds include ICON plc, Mass General Hospital, and UC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ping Zhang
researcher (ORCID 0000-0002-4873-4383)
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireGyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-
- Simply Wall St.US Undiscovered Gems 3 Promising Small Caps with Strong Potential As the S&P 500 and Nasdaq reach record highs, driven by optimistic expectations of Federal Reserve rate cuts following a steady infla